Journal of voice : official journal of the Voice Foundation · 2025
Therapeutic Outcomes of Vocal Fold Botulinum Toxin Injections for Exercise-Induced Laryngeal Obstruction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mailly Marie, Hans Stéphane, Lechien Jérôme R
Аннотация
OBJECTIVE: To investigate the effectiveness of vocal fold botulinum toxin injection (BTI) for treating patients with the glottic form of exercise-induced laryngeal obstruction (EILO).
METHODS: The outcomes of 13 patients treated with BTI for a confirmed diagnosis of EILO between May 2017 and July 2024 were retrospectively analyzed. Electromyography-guided bilateral BTI (1.5 IU Xeomin) was administered through the cricothyroid membrane approach. The BTI effectiveness was assessed at 3-month follow-up on the dyspnea and stridor. The number of BTIs, mean doses, and adverse events were collected.
RESULTS: The cohort included nine females and four males (mean age of EILO onset: 21 years), predominantly runners (n = 7), with all having reduced or stopped their high-intensity sport activities. Twelve patients (92.3%) reported symptom improvement after a single BTI, with the remaining patient responding to a second BTI with an increased dose. The mean duration of BTI effectiveness was 90 days (range: 30-180 days) for a mean follow-up period of 14 months. The mean number of BTI to reach a sustained symptom relief was 4.38. Transient mild aphonia occurred in 53.8% of patients following initial treatment.
CONCLUSION: Single or repeated BTIs into vocal folds are an alternative, safe, and effective procedure for treating isolated glottic EILO. Future large-cohort studies are needed to investigate its effectiveness on the long-term with comparison with voice therapy through multidimensional subjective and objective evaluations.
METHODS: The outcomes of 13 patients treated with BTI for a confirmed diagnosis of EILO between May 2017 and July 2024 were retrospectively analyzed. Electromyography-guided bilateral BTI (1.5 IU Xeomin) was administered through the cricothyroid membrane approach. The BTI effectiveness was assessed at 3-month follow-up on the dyspnea and stridor. The number of BTIs, mean doses, and adverse events were collected.
RESULTS: The cohort included nine females and four males (mean age of EILO onset: 21 years), predominantly runners (n = 7), with all having reduced or stopped their high-intensity sport activities. Twelve patients (92.3%) reported symptom improvement after a single BTI, with the remaining patient responding to a second BTI with an increased dose. The mean duration of BTI effectiveness was 90 days (range: 30-180 days) for a mean follow-up period of 14 months. The mean number of BTI to reach a sustained symptom relief was 4.38. Transient mild aphonia occurred in 53.8% of patients following initial treatment.
CONCLUSION: Single or repeated BTIs into vocal folds are an alternative, safe, and effective procedure for treating isolated glottic EILO. Future large-cohort studies are needed to investigate its effectiveness on the long-term with comparison with voice therapy through multidimensional subjective and objective evaluations.